$125 | Single User
$250 | Site License
$375 | Global License

Eisai Inc - Strategic SWOT Analysis Review [Report Updated: 03-01-2019]

Published by Global Data: 03 Jan 2019 | 228642 | In Stock

Introduction

Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemotherapy, Aloxi anti-nausea medication injection, Banzel for adjunctive treatment and Panretin for the treatment of skin lesions in AIDS-related Kaposi's sarcoma. The company’s research and development activities focus on therapeutic areas such as neuroscience; cancer, antibody-based programs; vascular, inflammatory and immunological reaction. Eisai established partnerships and collaborations with global companies such as Pfizer Inc., Janssen Pharmaceutica Inc., and Elan Pharma International Limited and Elan Pharmaceutical Inc for the development and distribution of drugs. The company is a subsidiary of Eisai Co., Ltd. and is headquartered in New Jersey, the US.

Eisai Inc Key Recent Developments

Sep 06,2018: Oncodesign furthers its cooperation with Eisai, started 12 years ago

Aug 31,2018: XingImaging announces alzheimer's disease PET imaging in Mainland China

Aug 27,2018: Eisai names Stephen Davies as vice president of its strategic information systems

Aug 27,2018: Stephen Davies appointed Vice President, Eisai strategic information systems at Eisai

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Eisai Inc - Strategic SWOT Analysis Review [Report Updated: 03-01-2019]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Section 1 - About the Company 5

    Eisai Inc - Key Facts 5

    Eisai Inc - Key Employees 6

    Eisai Inc - Key Employee Biographies 7

    Eisai Inc - Major Products and Services 8

    Eisai Inc - History 9

    Eisai Inc - Company Statement 12

    Eisai Inc - Locations And Subsidiaries 13

    Head Office 13

    Other Locations & Subsidiaries 13

    Section 2 – Company Analysis 14

    Company Overview 14

    Eisai Inc - Business Description 15

    Eisai Inc - Corporate Strategy 16

    Eisai Inc - SWOT Analysis 17

    SWOT Analysis - Overview 17

    Eisai Inc - Strengths 17

    Eisai Inc - Weaknesses 18

    Eisai Inc - Opportunities 19

    Eisai Inc - Threats 20

    Eisai Inc - Key Competitors 21

    Section 3 – Company’s Lifesciences Financial Deals and Alliances 22

    Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

    Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23

    Eisai Inc, Recent Deals Summary 24

    Section 4 – Company’s Recent Developments 25

    Sep 06, 2018: Oncodesign furthers its cooperation with Eisai, started 12 years ago 25

    Aug 31, 2018: XingImaging announces alzheimer's disease PET imaging in Mainland China 26

    Aug 27, 2018: Stephen Davies appointed Vice President, Eisai strategic information systems at Eisai 27

    Section 5 – Appendix 28

    Methodology 28

    About GlobalData 28

    Contact Us 28

    Disclaimer 28

List Of Tables
in Eisai Inc - Strategic SWOT Analysis Review [Report Updated: 03-01-2019]

List of Tables

Eisai Inc, Key Facts 5

Eisai Inc, Key Employees 6

Eisai Inc, Key Employee Biographies 7

Eisai Inc, Major Products and Services 8

Eisai Inc, History 9

Eisai Inc, Other Locations 13

Eisai Inc, Subsidiaries 13

Eisai Inc, Key Competitors 21

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23

Eisai Inc, Recent Deals Summary 24

List Of Figures, Charts and Diagrams
in Eisai Inc - Strategic SWOT Analysis Review [Report Updated: 03-01-2019]

List of Figures

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

Eisai Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 23

Additional Details

Publisher

Global Data

Publisher Information

Reference

228642 | GDPH98590SA

Number of Pages

28

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Eisai Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review
Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review provides you an in-depth strat...
09 Aug 2016 by Global Data USD $125 More Info
Eisai Co., Ltd. (4523) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryEisai Co., Ltd. (Eisai) is one of the leading pharmaceutical companies in Japan. It undertake...
29 Jul 2016 by Global Data USD $250 More Info
Eisai Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryEisai Inc. (Eisai) is a healthcare company, which focuses on the discovery, development and m...
29 Jul 2016 by Global Data USD $250 More Info
Eisai Inc. - Strategic SWOT Analysis Review
Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s hist...
03 May 2016 by Global Data USD $125 More Info
Eisai Co., Ltd. (4523) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryEisai Co., Ltd. (Eisai) is one of the leading pharmaceutical companies in Japan. It undertake...
12 Apr 2016 by Global Data USD $250 More Info
Eisai Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryEisai Inc. (Eisai) is a healthcare company, which focuses on the discovery, development and m...
12 Apr 2016 by Global Data USD $250 More Info
Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review
Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review provides you an in-depth strat...
22 Mar 2016 by Global Data USD $125 More Info
Eisai Co., Ltd. (4523) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryEisai Co., Ltd. (Eisai) is one of the leading pharmaceutical companies in Japan. It undertake...
03 Mar 2016 by Global Data USD $250 More Info
Eisai Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryEisai Inc. (Eisai) is a healthcare company, which focuses on the discovery, development and m...
03 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Eisai Inc - Strategic SWOT Analysis Review [Report Updated: 03-01-2019] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data